This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine.
This application also relates to processes for preparing a compound of formula I, and intermediate compounds useful therein.
The present invention provides compounds of formula (I); pharmaceutical compositions thereof, and methods of using the same, processes or preparing the same, and intermediates thereof.
本发明提供了式(I)的化合物;其制药组合物,使用方法,制备方法或中间体。
Potentiators of Glutamate Receptors
申请人:Eli Lilly and Company
公开号:EP2441762A1
公开(公告)日:2012-04-18
The present invention provides compounds of formula I:
pharmaceutical compositions thereof, and methods of using the same, processes or preparing the same, and intermediates thereof.